Zoetis Stock News

Zoetis (ZTS) delivered earnings and revenue surprises of 0% and 1.72%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Animal health giant Zoetis beat fourth-quarter sales expectations Tuesday and issued a strong 2023 outlook, leading ZTS stock to pop. The post Zoetis Snags A Quarterly Sales Beat And Issues A Strong 2

COLL vs. ZTS: Which Stock Is the Better Value Option?

These investments seem pretty vulnerable right now.

COLL vs. ZTS: Which Stock Is the Better Value Option?

These investments seem pretty vulnerable right now.

Higher sales of Zoetis' (ZTS) key drugs like Apoquel, Cytopoint, Simparica Trio, Librela and Solensia are expected to have driven sales, partially offset by lower sales of livestock, cattle, poultry a

Zoetis (ZTS) closed the most recent trading day at $160.81, moving -0.78% from the previous trading session.

Zoetis (ZTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zoetis (ZTS) closed at $171 in the latest trading session, marking a +1.9% move from the prior day.

I present my top 15 high-growth dividend stocks to consider during the month of February. The watchlist posted a gain of 9.44% in January and starts the new year on a positive note.

These businesses offer powerful passive income potential, growing their dividends between 178% and 481% over the last five years.

These businesses offer powerful passive income potential, growing their dividends between 178% and 481% over the last five years.

Zoetis (ZTS) closed at $165.18 in the latest trading session, marking a -1.82% move from the prior day.

UTHR vs. ZTS: Which Stock Is the Better Value Option?